Brief: SomaLogic Reports Fourth Quarter Loss Per Share Of $0.13
29/03/2022 21:12
March 29 (Reuters) - SomaLogic Inc SLGC.O :
* SOMALOGIC REPORTS FOURTH QUARTER AND FULL YEAR 2021
FINANCIAL
RESULTS
* Q4 LOSS PER SHARE $0.13
* SEES FY REVENUE $105 MILLION TO $110 MILLION
* Q4 REVENUE FELL 18.5 PERCENT TO $23 MILLION
Source text for Eikon: ID:nGNX6J49Xc
Further company coverage: SLGC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Somalogic
See all newsBrief: Somalogic Stockholders Vote To Approve Standard Biotools Transaction At Special Meeting
Brief: Madryn Asset Management Demands Somalogic’S Board Address Repeated, Unprecedented Adjournments Of Tainted Special Meeting
Brief: Madryn Asset Management Says It Urges All Somalogic Shareholders To Oppose Transaction With Standard Biotools
Brief: Madryn Asset Management Urges Shareholders To Vote “Against” The Proposed Merger And Allow Somalogic To Pursue Value-Enhancing Alternatives
Brief: Somalogic Board Reiterates Value-Maximizing Transaction With Standard Biotools Is In Best Interests Of All Stockholders